Developing a Fluorescence-Based High-Throughput Screening Method for Natural Product Fractions to Identify Inhibitors of AR-V7 for Castration-Resistant Prostate Cancer
Neha Tyagi, Manish Rathi, Susan Ensel, Christopher C. Thornburg, Tanja Grkovic, Barry R. O’Keefe, James C. Sacchettini, Chendil Damodaran · 2026
Read Developing a Fluorescence-Based High-Throughput Screening Method for Natural Product Fractions to Identify Inhibitors of AR-V7 for Castration-Resistant Prostate Cancer by Neha Tyagi, Manish Rathi, Susan Ensel, Christopher C. Thornburg, Tanja Grkovic, Barry R. O’Keefe, James C. Sacchettini, Chendil Damodaran (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13610743.txt.
Description
Neha Tyagi and co-authors build a screening platform to find plant compounds that block a stubborn prostate cancer driver in a 2026 paper. Advanced prostate cancer often escapes hormone therapy through a shortened receptor variant, AR-V7, that stays always on. Natural products are a rich hunting ground for blockers.
Their assay uses cancer cells edited so the variant carries a glowing tag, letting machines read its level quickly. From 704 plant extract fractions, five passed strict tests for power and safety against normal cells. Three of them lowered both the variant and the normal receptor. Sub-screening pinned the activity to two named compounds, butanolides from a plant source. The platform is offered as a fast lane for natural product discovery.
Catalog record
| CREATOR | Neha Tyagi, Manish Rathi, Susan Ensel, Christopher C. Thornburg, Tanja Grkovic, Barry R. O’Keefe, James C. Sacchettini, Chendil Damodaran |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 38 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |